丽珠医药7月30日斥资299.11万元回购7.14万股A股

Core Viewpoint - Lijun Pharmaceutical (01513) announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Summary by Category Company Actions - The company plans to repurchase 71,400 A-shares at a total cost of RMB 2.9911 million [1] - The buyback price ranges from RMB 41.78 to RMB 41.99 per share [1] Financial Implications - The total expenditure for the buyback reflects the company's strategy to enhance shareholder value [1]